When did IDEX BIOMETRICS ASA (IDEX.OL) report earnings last quarter?
IDEX BIOMETRICS ASA (IDEX.OL) last reported earnings on 3/3/2026.
OSL:IDEX • NO0013536078
Past quarterly earnings results for IDEX BIOMETRICS ASA (IDEX.OL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in NOK): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | - | - | - | -100.00% | ||||
| Q2 2025 | -0.07 | - | -250.00% | 80K | - | -79.49% | ||
| Q1 2025 | - | - | 104K | - | -72.04% | |||
| Q4 2024 | 0.00 | - | 100.00% | 20K | - | -95.83% | ||
| Q3 2024 | - | - | 60K | - | -93.68% | |||
| Q2 2024 | -0.02 | - | 99.96% | 390K | - | -97.51% | ||
| Q1 2024 | - | - | 372K | - | -97.07% | |||
| Q4 2023 | -0.02 | -0.05 | 56.30% | - | 480K | 11.442M | -95.80% | -54.97% |
| Q3 2023 | -0.01 | -4.12 | 99.76% | - | 950K | 21.128M | -95.50% | 2.37% |
| Q2 2023 | -46.39 | -1,786.34 | 97.40% | - | 15.656M | 19.015M | -17.67% | 1,313.00% |
| Q1 2023 | -44.23 | -1,877.95 | 97.65% | - | 12.709M | 15.846M | -19.80% | 1,185.04% |
| Q4 2022 | 0.00 | - | 100.00% | 1.066M | - | 35.45% | ||
| Q3 2022 | -0.01 | - | - | 928K | - | 26.78% | ||
| Q2 2022 | - | - | 1.108M | - | 58.97% | |||
| Q1 2022 | - | - | 989K | - | 58.49% | |||
| Q4 2021 | -0.02 | - | 77.78% | 787K | - | 31.61% | ||
| Q3 2021 | - | - | 732K | - | 195.16% | |||
| Q2 2021 | -0.01 | - | 88.51% | 697K | - | 367.79% | ||
| Q1 2021 | -0.09 | - | -1.19% | 624K | - | 524.00% | ||
| Q4 2020 | -0.09 | - | - | 598K | - | - | ||
| Q3 2020 | -0.09 | - | - | 248K | - | - | ||
| Q2 2020 | -0.09 | - | - | 149K | - | - | ||
| Q1 2020 | -0.08 | - | - | 100K | - | - |
Notes
IDEX BIOMETRICS ASA (IDEX.OL) last reported earnings on 3/3/2026.
IDEX BIOMETRICS ASA (IDEX.OL) missed EPS estimates and missed revenue estimates in the most recent quarter.